All Pharma News
price-trendAsk Us
SynOx Secures $35M Debt For Emactuzumab Commercialization

SynOx Secures $35M Debt For Emactuzumab Commercialization
PR NEWSWIRE
30 Apr 2024
Share Share
SynOx Therapeutics Secures up to $35m Debt Financing

SynOx Therapeutics Secures up to $35m Debt Financing
PHARMACEUTICAL MANUFACTURING
30 Apr 2024
Share Share
SynOx Raises $75M Series B For TGCT Phase 3

SynOx Raises $75M Series B For TGCT Phase 3
PR NEWSWIRE
22 Apr 2024
Share Share
Emactuzumab designated as an Orphan Medicinal Product in Europe

Emactuzumab designated as an Orphan Medicinal Product in Europe
PRNEWSWIRE
31 Aug 2022
Share Share
SnyOx taps chief medical, tech officers week after CEO hire

SnyOx taps chief medical, tech officers week after CEO hire
Kyle LaHucik FIERCEBIOTECH
03 Aug 2021
Share Share
Ex-Kiadis CBO takes the helm at SynOx after $358M Sanofi buyout

Ex-Kiadis CBO takes the helm at SynOx after $358M Sanofi buyout
FIERCEBIOTECH
27 Jul 2021
Share Share
Ex-Kiadis CBO takes the helm at SynOx after $358M Sanofi buyout

Ex-Kiadis CBO takes the helm at SynOx after $358M Sanofi buyout
FIERCEBIOTECH
27 Jul 2021
Share Share